Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-06
2007-11-06
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S232800, C514S253030, C514S293000, C514S405000, C540S524000, C544S126000, C546S082000, C548S359500
Reexamination Certificate
active
11442548
ABSTRACT:
The present invention relates to novel heterocyclic compounds, to methods for their preparation, to compositions containing them, and to methods and use for clinical treatment of medical conditions which may benefit from immunomodulation, including rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis. More particularly the present invention relates to novel heterocyclic compounds, which are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28.
REFERENCES:
patent: 4268516 (1981-05-01), Lombardino et al.
patent: 4312870 (1982-01-01), Yokoyama
patent: 4758427 (1988-07-01), Leeson
patent: 6642249 (2003-11-01), Bjork et al.
patent: 91/11448 (1991-08-01), None
patent: 91/12255 (1991-08-01), None
patent: 97/34893 (1997-09-01), None
patent: 03/004495 (2003-01-01), None
L. Savini et al., “High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones”, Bioorganic & Medicinal Chemistry, vol. 9, No. 2, Feb. 2001, pp. 431-444.
V. Colotta et al., Tricyclic Heteroaromatic Systems: Synthesis, [3H] Flunitrazepam Brain Membrane Binding Inhibition, and Structure-Activity Relationships of 2,3-Dihydro-2-aryl-4-R-[1]benzopyrano[4,3-c]pyrazole-3-ones, Journal of Pharmaceutical Sciences, vol. 78, No. 3, Mar. 1989, pp. 239-242.
European Search Report dated Jun. 15, 2007.
International Search Report dated Feb. 5, 2004.
David v. Erbe et al., “Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1”, J. Biol. Chem., vol. 277, Issue 9, 7363-7368, Mar. 1, 2002.
Brennan Chris James
Coutler Thomas Stephen
da Graca Thrige Dorthe
Ghiron Chiara
Huxley Philip
Active Biotech A.B.
Buchanan & Ingersoll & Rooney PC
Powers Fiona T.
LandOfFree
Immunomodulatory compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunomodulatory compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulatory compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828883